| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 394.7K | $3.94M | - | |
| Other | 389.3K | $3.88M | - | |
| Other | 330.7K | $3.30M | - | |
| Other | 326.3K | $3.25M | - | |
| Other | 323.4K | $3.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,814 | $9.00 | $16,326.00 | -1.0% | -26.1% | +33.4% | |
| Nov 25, 2024 | Dugel Pravin | See Remarks | Sell | 20,680 | $9.01 | $186,326.80 | -2.5% | -26.1% | +33.4% | |
| Aug 23, 2024 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,832 | $9.02 | $16,524.64 | -1.0% | -6.5% | +35.0% | |
| Aug 23, 2024 | Dugel Pravin | See Remarks | Sell | 20,880 | $9.02 | $188,337.60 | -2.5% | -6.5% | +35.0% | |
| May 23, 2024 | Nayak Sanjay | Chief Strategy Officer | Sell | 2,274 | $5.84 | $13,280.16 | -1.3% | +59.1% | +25.9% | |
| May 23, 2024 | Dugel Pravin | See Remarks | Sell | 21,626 | $5.79 | $125,214.54 | -2.5% | +59.1% | +25.9% | |
| Feb 26, 2024 | Summer Road LLC47 | - | Buy | 930,851 | $7.52 | $6,999,999.52 | +12.2% | -40.1% | -31.6% | |
| Feb 5, 2024 | White Christopher G | Chief Business Officer | Sell | 5,910 | $4.86 | $28,722.60 | -4.6% | +17.2% | +58.0% | |
| Feb 5, 2024 | Ozden Rabia Gurses | Chief Medical Officer | Sell | 6,346 | $4.86 | $30,841.56 | -4.0% | +17.2% | +58.0% | |
| Feb 5, 2024 | Notman Donald | Chief Financial Officer | Sell | 6,212 | $4.86 | $30,190.32 | -3.1% | +17.2% | +58.0% |